GitDealFlowsignals

Healthcare · sub-niche

Clinical trial recruitment software.

Patient matching for clinical trials, with AI eligibility screening.

Team-sized buildSteady, one deal per month

Reading the two labels: team-sized build build cost means only makes sense as a team bet, multiple quarters of salary before any revenue, the kind of project incumbents are better positioned to start. Steady, one deal per month deal velocity means a round closes somewhere in this category most quarters, neither hot nor dead.

Quick take: Clinical trial recruitment software is a team-sized build-cost, steady, one deal per month-velocity opportunity inside Healthcare, with 3 public reference points. Pharma is the buyer; sales cycles are 12-24 months. Fund only with biotech or pharma-adjacent founders. The moat is the eligibility-criteria library + the EHR integration footprint.

Why now

Trial enrollment is the bottleneck of pharma R&D. AI can match patients to protocols 10x faster.

What the signal looks like

Repos with clinical-criteria parsers, EHR data adapters, and recruitment-funnel libraries.

Public examples

We name publicprojects + categories only, never founders we track inside the paid product. The buyer’s edge stays inside the product.

  • Antidote / Deep 6 AI-style platforms
  • EHR-integrated recruitment
  • Patient portal trial-matching

What this displaces

A CRO calling patients from a list.

How to validate it in an afternoon

Before committing build time or a thesis memo to clinical trial recruitment software, run three cheap checks against public engineering activity. Each takes minutes and none require access to private data.

  1. Count active builders. Search GitHub for repositories matching this category, then check how many accepted commits in the last 14 days. More than a handful of active teams means the category has energy, not just mentions.
  2. Look for the steady, one deal per month pattern in funding. If funded companies keep appearing here, a round closes somewhere in this category most quarters, neither hot nor dead. Cross-check the healthcare leaderboard to see whether any of the accelerators sit adjacent to this niche.
  3. Test the team-sized build cost assumption honestly: only makes sense as a team bet, multiple quarters of salary before any revenue, the kind of project incumbents are better positioned to start. If your calendar cannot absorb that, the opportunity is real but not yours yet.

The weekly signal feed tracks 10 Healthcare sub-niches including this one, so the cohort side of this check can run continuously instead of manually.

Our build-vs-invest call

Pharma is the buyer; sales cycles are 12-24 months. Fund only with biotech or pharma-adjacent founders. The moat is the eligibility-criteria library + the EHR integration footprint.

Common questions about this niche

Who pays?
Pharma sponsors and CROs.
Pricing?
Per-patient enrolled or per-trial.
Compliance?
HIPAA + GCP + IRB workflows.

Five breakout startups, every Sunday, before the round gets crowded

The free Acceleration Watch: five venture-backed teams accelerating on the engineering signal, translated into plain English, 21 to 47 days before the deck circulates. No code-reading, no card.

Signed The Data Nerd · pseudonymous narrator · methodology over personality

More inside Healthcare

See all 10 Healthcare sub-niches →

Last refreshed: . Editorial commentary; not investment advice.

Methodology + data source: /methodology. Named scoreboard: /startups-to-watch.

🚀 Explore Our Network

21-47 days
Signal Lead Time (median 31d)
$80M+
Rounds Tracked
90 sec
Per Scan
5,000+
Founders Tracked

One missed signal is a missed round. Get the Velocity Verdict in your inbox every Sunday free.

Get Free Signals

Free weekly digest. Cancel anytime. No spam, no VC pitches just data.